Maxcyte (MXCT) Depreciation & Amortization (CF) (2020 - 2026)

Maxcyte (MXCT) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 4.47% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 0.21% change from a year earlier, with the FY2025 full-year figure at $4.3 million, up 0.58% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for MXCT reached as high as $1.1 million in Q1 2024 and fell as low as $487400.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $974752.9 across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Depreciation & Amortization (CF) jumped 120.82% in 2022 and fell 4.47% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $919700.0 in 2022, then climbed by 19.82% to $1.1 million in 2023, then declined by 4.08% to $1.1 million in 2024, then gained by 1.42% to $1.1 million in 2025, then dropped by 2.33% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.